Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1989-09-20
1999-07-13
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
514 18, 514 19, 514912, 514913, 514914, 514915, 530300, A61K 3848
Patent
active
059223197
ABSTRACT:
A method of reducing corneal scarring or fibroblast proliferation comprises applying to an area of a subject's eye afflicted with the condition a corneal scar-fibroblast proliferation-reducing amount of a free or polymer-bound HLE inhibitory agent under conditions and for a period of time effective to attain the desired effect. A method of reducing neovascularization of corneal scar tissue comprises applying to an area of a subject's eye afflicted with the condition a neovascularization-inhibitory amount of a free or polymer-bound HLE inhibitory agent under conditions and for a period of time effective to attain the desired effect.
REFERENCES:
patent: 4609667 (1986-09-01), Clark
patent: 4613587 (1986-09-01), Kessler
patent: 4643991 (1987-02-01), Digenis et al.
patent: 5008245 (1991-04-01), Digenis
Krummel et al. J Pediatric Surgery vol. 23. No. 7. (1988) pp. 647-652.
Siebert et al. Plastic and Reconstructive Surgery (1990) vol. 85. No. 4. pp. 495-502.
Skuta et al. Survey of Opthalmology vol. 32 No. 3. pp. 149-170, 1987.
Schmut, et al. BIOSIS Abstract No. 86:441139 1986.
Luce, J.M. Biol. Abstracts 81(3) AB-839. Abstract No. 126950 (1985).
Chesnokova N. et al. Chem Abstracts v. 105, Abstract No. 131573y (1986).
Tuhy et al., "Inhibition of Human Leukocyte Elastase by Peptide Chloromethyl Ketones,", FEBS Letters, 50, 359-61 (1975).
Powers et al., "Specificity of Porcine Pancreatic Elastase, Human Leukocyte Elastase and Cathespin G. Inhibition with Peptide Chloromethyl Ketones," Biochem. Biophys. Acta. 485, 156-66 (1977).
Dorn et al., "Proteinase Inhibitors. 1. Inhibitors of Elastase" J.Med. Chem. 20: 1464-68 (1977).
Yoshimura et al., Specificity and Reactivity of Human Leukocyte Elastase, Porcine Pancreatic Elastase, Human Granulocyte Cathespin G, and Bovine Pancreatic Chymotrpsin with Arylsulfonyl Fluorides, J. Biol. Chem 257, 5077-84 (1982).
Zimmerman et al., "Inhibition of Elastase and Other Serine Proteases by Heterocyclic Acylating Agents", J. Biol. Chem. 255: 9848-51 (1980).
Ashe et al., "Selective Inhibition of Human Leukocyte Elastase and Bovine A-Chymotrypsin by Novel Hetercycles," J. Biol. Chem. 256: 11603-6 (1981).
Scofield et al., "p-Nitrophenyl Carbamates as Active-Site-Specific Reagents for Serine Proteases," Biochemistry, 16: 2492 (1977).
Janoff et al., "Prevention of Elastase Induced Experimental Emphysemia by Oral Administration of a Synthetic Elastase Inhibitor," Am. J. Respir. Dis., 121: 1025-3 (1980).
Digenis George A.
Khouri Charles
Sayala Chhaya D.
University of Kentucky Research Foundation
LandOfFree
Methods of treating eye conditions with human leukocyte elastase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating eye conditions with human leukocyte elastase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating eye conditions with human leukocyte elastase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2273415